Navigation Links
MDS Pharma Services Opens Largest Phase I Clinic on U.S. West Coast
Date:1/25/2008

New 300-bed facility in Tempe, Arizona, raises MDS capacity in the

Phoenix-area to 420 total beds

KING OF PRUSSIA, PA, Jan. 25 /PRNewswire-FirstCall/ - MDS Pharma Services (http://www.mdsps.com), a leading provider of innovative drug discovery and development solutions, has expanded its presence in the Phoenix area with a new 300-bed Phase I facility in nearby Tempe, Arizona. The $25 million facility more than doubles the previous MDS Phase I capacity in Phoenix to 420 total beds to meet the growing needs of its pharmaceutical and biotech clients. Part of an extensive global network of European and North American Phase I locations, the new facility brings the MDS Pharma Services global total to more than 1,100 beds.

In addition to a specialized area for conducting cardiac safety trials, the new facility also offers specialized ophthalmic capabilities, as well as a range of other specialty Phase I services. Purpose-built from the ground up to be a Phase I clinic, the new facility has a state-of-the art clinical lab and secure pharmacy, comfortable accommodations for study participants and well-appointed areas for visiting clients.

"Client needs were top-of-mind when we decided to expand in Phoenix - the fastest growing urban area in the United States," said MDS Pharma Services President David Spaight. "The Phoenix location offers several advantages to our clients, including travel convenience, access to a large and varied study participant pool, and an experienced and educated workforce to staff the new clinic and laboratory."

The workforce for the new facility is drawn from the same experienced team that operated the earlier MDS Pharma Services Phoenix clinic, where they achieved a better than 97% on-time study start-up record. MDS Pharma Services has had a Phase I operation in Phoenix for more than two decades, conducting more than 600 clinical trials involving some 13,000 participants. Its current Phoenix workforce of more than 150 could triple when the new facility is running at full capacity.

About MDS Pharma Services

MDS Pharma Services is committed to delivering quality results on time. We offer a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at http://www.mdsps.com.

MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 28 countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Pharma Services
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
2. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
3. URAC Seeks Public Comment on Standards for New Pharmacy Accreditation Programs
4. AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors Out of the Closet & AHF Pharmacy
5. KV Pharmaceutical Company Announces Acquisition of Rights to Gestiva(TM)
6. Pharmacists believe drive-through windows contribute to delays, errors
7. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
8. Pharmaceutical market fails pregnant women; and more
9. FLAVORx Teams up with Wedgewood Pharmacy to Make it Even Easier to Make Pet Medications Taste Good
10. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
11. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... Prophecy concerning this present generation. Yisrayl makes an astounding statement when he says ... He explains that the Bible details the current times so plainly that anyone should ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... will return to the La Gorce Country Club in Miami Beach to host ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... in thought leadership , media relations, content marketing, social media management, corporate ... several clients already in the state and in nearby New Hampshire, Massachusetts and ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Pharma To Market Pty Ltd and Ador Consulting Pte Ltd announce ... of Pharma To Market Pte Ltd, based in Singapore ... their expansion into Asia with the opening ... are delighted to appoint Joelle Chia , former owner of ... based entity. Joelle brings with her an extensive business network throughout ...
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
Breaking Medicine Technology: